Myriad Genetics, Inc. Live Share Price Today, Share Analysis and Chart

Name: Myriad Genetics, Inc.: Is Infosys Ltd. worth buying?
Item: Myriad Genetics, Inc.
Rating: 1.227208375
Author: Trendlyne DVM scores

Momentum Trap

about

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11...

5.72 0.17 (3.06%)

80.48% Fall from 52W High

963.7K

XNAS Volume

XNAS 09 Jul, 2025 5:30 PM (EDT)

Low Financial Strength

16.7 / 100

Expensive Valuation

28.3 / 100

Technically Neutral

36.5 / 100

Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

1Yr Price target upside is 33%

13 analysts

Myriad Genetics, Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Myriad Genetics, Inc. Live Share Price Today, Share Analysis and Chart

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11...

80.48% Fall from 52W High

SWOT Analysis

Myriad Genetics, Inc. Live Price Chart